PCI Pharma Services, a global contract development and manufacturing organisation (CDMO) focused on innovative biopharma therapies, has completed its acquisition of Ajinomoto Althea.
PCI Pharma Services – a global contract development and manufacturing organisation (CDMO) focused on innovative biopharma therapies – is acquiring an entire equity stake in Ajinomoto Althea.
Tecan Group has announced an agreement to acquire certain assets relating to key ELISA immunoassay products from Cisbio Bioassays SAS, a subsidiary of the global life sciences and diagnostics company, Revvity.
Rimkus Consulting Group has announced the acquisition of Human Factors Consulting Services, Incorporated (“HFCSI”), a highly regarded firm specialising in proactive human factors services and medical device consulting.
Cold Chain Technologies, a global provider of advanced thermal packaging and digital monitoring solutions for the transportation of temperature-sensitive life sciences products, has announced it has acquired Global Cold Chain Solutions.
ProductLife Group (PLG) has announced the acquisition of HERAX Life Science, a Danish business and technology consultancy providing tailored services and solutions for the life sciences industry.
After the pharmaceutical industry’s muted mergers and acquisitions (M&A) landscape in 2024, Nick Petschek, EMEA MD at Kotter International suggests many expect M&A to pick back up in 2025.
Advanced Material Processing (AMP) and Automated Handling Solutions (AHS), have announced their merger and rebranding as Akona Process Solutions (Akona), a portfolio company of Chicago-based, May River Capital.
FUJIFILM Irvine Scientific, a specialist in the innovation and manufacture of cell culture solutions for the life science and medical markets, has announced it entered into an agreement to sell its Medical Media Business Unit (MBU) to Astorg.
